Oral insulin delivery by means of solid lipid nanoparticles

Int J Nanomedicine. 2007;2(4):743-9.

Abstract

The aim of this work was to produce and characterize cetyl palmitate-based solid lipid nanoparticles (SLN) containing insulin, and to evaluate the potential of these colloidal carriers for oral administration. SLN were prepared by a modified solvent emulsification-evaporation method based on a w/o/w double emulsion. The particle size, zeta potential and association efficiency of unloaded and insulin-loaded SLN were determined and were found to be around 350 nm, negatively charged and the insulin association efficiency was over 43%. After oral administration of insulin-loaded SLN to diabetic rats, a considerable hypoglycemic effect was observed during 24 hours. These results demonstrated that SLN promote the oral absorption of insulin.

MeSH terms

  • Administration, Oral
  • Animals
  • Blood Glucose / analysis*
  • Diabetes Mellitus / blood*
  • Diabetes Mellitus / drug therapy*
  • Drug Carriers / chemistry*
  • Insulin / administration & dosage*
  • Male
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Palmitates / chemistry*
  • Rats
  • Rats, Wistar
  • Treatment Outcome

Substances

  • Blood Glucose
  • Drug Carriers
  • Insulin
  • Palmitates
  • cetyl palmitate